chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I21.09 ACUTE ST ELEVATION MI, ANTERIOR WALL 8/28/2021 ATHEROSCLEROSIS OF AORTA I21.3 ACUTE ST ELEVATION MI, UNSPECIFIED 8/28/2021 ATHEROSCLEROSIS OF AORTA I21.9 ACUTE MI 8/28/2021 ATHEROSCLEROSIS OF AORTA R57.0 CARDIOGENIC SHOCK 8/29/2021 ATHEROSCLEROSIS OF AORTA I21.09 ACUTE ST ELEVATION MI, ANTERIOR WALL 8/28/2021 DO NOT RESUSCITATE STATUS I21.3 ACUTE ST ELEVATION MI, UNSPECIFIED 8/28/2021 DO NOT RESUSCITATE STATUS I21.9 ACUTE MI 8/28/2021 DO NOT RESUSCITATE STATUS R57.0 CARDIOGENIC SHOCK 8/29/2021 DO NOT RESUSCITATE STATUS I21.09 ACUTE ST ELEVATION MI, ANTERIOR WALL 8/28/2021 ACUTE ST ELEVATION MI, UNSPECIFIED I21.3 ACUTE ST ELEVATION MI, UNSPECIFIED 8/28/2021 ACUTE ST ELEVATION MI, UNSPECIFIED I21.9 ACUTE MI 8/28/2021 ACUTE ST ELEVATION MI, UNSPECIFIED R57.0 CARDIOGENIC SHOCK 8/29/2021 ACUTE ST ELEVATION MI, UNSPECIFIED I21.09 ACUTE ST ELEVATION MI, ANTERIOR WALL 8/28/2021 AORTIC VALVE STENOSIS I21.3 ACUTE ST ELEVATION MI, UNSPECIFIED 8/28/2021 AORTIC VALVE STENOSIS I21.9 ACUTE MI 8/28/2021 AORTIC VALVE STENOSIS R57.0 CARDIOGENIC SHOCK 8/29/2021 AORTIC VALVE STENOSIS I21.09 ACUTE ST ELEVATION MI, ANTERIOR WALL 8/28/2021 CARDIOGENIC SHOCK I21.3 ACUTE ST ELEVATION MI, UNSPECIFIED 8/28/2021 CARDIOGENIC SHOCK I21.9 ACUTE MI 8/28/2021 CARDIOGENIC SHOCK R57.0 CARDIOGENIC SHOCK 8/29/2021 CARDIOGENIC SHOCK
second day after vaccine, 1/8/2021, around 4 PM, my left arm started to hurt really bad, that I had a hard time moving my left hand, it shot up into my left neck and my left face and left front of head had numbness, lasted about 45 minutes to an hour, I had a slight headache earlier that day, nothing the day before of the shot other than a bit of arm soreness at the site, I am pretty healthy, in shape, and work out regular, 5 feet 3 inches and 124 pounds, No major health issues. This numbness in my face and head and severe arm pain has not returned but scared with second shot, I still been experiencing slight left-sided headaches  nothing bad but I never previously had headaches before vaccine, So many I know did not have any side effects from first, and now wondering why I did and fearful of second shot now. thank you, so much for any help, I truly appreciate it, and thank you all for what you do for us.
Spotting between period; Extended period circle from 3 days to 7 days; Excruciating pain; cramps; This is a spontaneous report from a contactable consumer. The reporter is the patient.  A 38 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Apr2021 17:30 (Lot number: EW0162) at the age of 38 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: INTERMENSTRUAL BLEEDING (non-serious) with onset May2021, outcome "not recovered", described as "Spotting between period"; HEAVY MENSTRUAL BLEEDING (non-serious) with onset May2021, outcome "not recovered", described as "Extended period circle from 3 days to 7 days"; PAIN (non-serious) with onset May2021, outcome "not recovered", described as "Excruciating pain"; MUSCLE SPASMS (non-serious) with onset May2021, outcome "not recovered", described as "cramps". Therapeutic measures were not taken as a result of intermenstrual bleeding, heavy menstrual bleeding, pain, muscle spasms.  Additional Information: Facility where the most recent COVID-19 vaccine was administered reported as Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The other medications the patient received within 2 weeks of vaccination reported as Nil. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 18-MAY-2013, a healthcare provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In 2017, the patient was treated by a healthcare provider at a hospital for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Shoulders and elbows pain for 3 yrs, short breath, sleeping problems, erectile dysfunction. Thigh pain.
1.5 days after vaccination, patient started uncontrollably vomiting dark green liquids, seen in EC and discharged.
hearing loss in the left ear; pain on the left side of neck; buzzing in the left ear; Initial information received on 29-Oct-2019 regarding an unsolicited valid serious case received from a consumer/non-healthcare professional.  This case involves a 65 years old female patient who experienced hearing loss in the left ear (deafness), pain on the left side of neck (neck pain) and buzzing in the left ear (tinnitus), while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 14-Oct-2019, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot number not reported via unknown route in the left arm.  On an unknown date, the patient developed a serious hearing loss in the left ear (deafness), Unknown latency following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. This event was assessed as medically significant.  On an unknown date, the patient developed a non-serious pain on the left side of neck (neck pain) and buzzing in the left ear (tinnitus), Unknown latency following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  It was reported that patient sought treatment at an ENT (ears, nose and throat) for the ear. She stated the ENT said there was no fluid in the ear but she had hearing loss due to an audible nerve virus.   Other relevant tests were not reported.  Final diagnosis was buzzing in the left ear, pain on the left side of neck and hearing loss in the left ear.   The patient was treated with weekly CORTISONE drops for 4 weeks.  On an unknown date, the  patient had recovered from neck pain (subsided in 3-4 hours without intervention) and not recovered from the other events.  Information on the batch number was requested.; Sender's Comments: Patient experienced deafness, neck pain and tinnitus after vaccination. Time to onset is unknown. However, further information including patient's medical history, concomitant medications, previous vaccination and tolerance, laboratory investigations excluding other etiology would be needed to fully assess this case. Based on available information the role of vaccine cannot be assessed.
Injection arm very sore/painful to lift starting the morning after the injection, followed by full body aches, fatigue, intense chills, 101.6 degree temp, diarrhea, & dull headache throughout the day that subsided in the late evening. Sore arm remains.
Patient received flu shot and went home and immediately started new treatment with Lisinopril. That evening started having groin, hip and back pain feeling like have a cold in spine and difficulty moving around, took hot shower that night and next am to help move. Also complaining about pain (tightness) across chest. As of 9/19/18 5:47 pm chest, groin and hip are both better but back pain persists. Patient says feels like muscle and joint tightness equals pain. Patient has not spoken or seen doctors of today.
Patient was given 0.2 ml of  Pfizer-BioNTech 12 and up dose, instead of the recommended Pfizer vaccine for ages 5-11.
Abdominal cramps; Sweating; headache; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Abdominal cramps), HYPERHIDROSIS (Sweating), HEADACHE (headache), NAUSEA (nausea) and FATIGUE (fatigue) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced ABDOMINAL PAIN (Abdominal cramps), HYPERHIDROSIS (Sweating), HEADACHE (headache), NAUSEA (nausea) and FATIGUE (fatigue). On 02-Mar-2021, ABDOMINAL PAIN (Abdominal cramps), HYPERHIDROSIS (Sweating), HEADACHE (headache), NAUSEA (nausea) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment drugs were reported.
Day 2 of 1/5/2021 vaccine, temp of 102.4 day 3, temp of 100.5 day 4 temp of 100.5 day5  temp normal
headaches for 3 days Starting on 11/30/2020, and Facial drooping on 12/2/2020.  GLYCERIN-HYPROMELLOSE-PEG 400 (ARTIFICIAL TEARS) 0.2-0.2-1 % SOLN    Administer 1 drop into the right eye 4 times daily as needed for Dry Eyes for up to 7 days. Order Dose: 1 drop PREDNISONE (DELTASONE) 20 MG TABLET    Take 3 tablets by mouth daily for 7 days. Order Dose: 60 m VALACYCLOVIR (VALTREX) 500 MG TABLET    Take 2 tablets by mouth 3 (three) times daily for 7 days. Order Dose: 1,000 mg.    Is being sent to Physical Therapy
Chest pain, feel like blockage to chest area, worsening on deep breathing and laying down, get some relief once sit up or stand up. Had short period of fast heart beats on Sunday night, but went away after a few hours.
Wheezing, Fast Breathing, Trouble Breathing and temperature of 100.6 (was checked by Dr. on 3/24/2010 and he said it definitely was not croup--it was wheezing and he was put on xopenex on the nebulizer--don't know it will help.  Still waiting to see as of 2:20pm on 3/24/2010
experienced a case of shingles; This case was reported by a consumer via sales rep and described the occurrence of shingles in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 2 weeks after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details provided were as follows: The age at vaccination was not reported. The patient received 2nd dose of Shingrix vaccine and after 2 weeks patient experienced Shingles. The reporter consented to follow-up. No further information received.
0.2ml COVID vaccine (monovalent 5-11yr) withdrawn from vial and given to patient at approx 830am. This vial should have been diluted per manufacturer instruction. Vial was not diluted prior to administration.  Error discovered at approx 115pm. Parents called and told of error and advised to watch for increased reaction after shot. I called dad on 1/25/23 at approx 1030am. He stated patient had increased lethargy and chills following the vaccine. Dad stated that symptoms were continuing to improve since 1/23/23. Pt also should have had bivalent dose as 3rd dose but was given a 3rd monovalent dose.
Information has been received from a registered nurse concerning a patient who on 30-Jan-2008 was inadvertently vaccinated with a dose of VARIVAX (Merck) (route and administrating site not reported) instead of ZOSTAVAX (Merck). Additional information has been requested.
Mother brought child back into clinic today 6-7-07 at 12:30 P.M. right thigh noted to have reddened, warm area of 1 3/4" in greatest diameter by 1 1/2" from top to bottom. Mom states redness began this am 6-7-07. Vaccine administered 6/5/07 at approximately 3:30 P.M.
Fever or Chills  Fatigue  Muscle or body aches  Headache  Sore throat  Congestion or running nose
Absent seizures, severe nose bleed, behavior challenge. The absent seizures lasted over night and into the next day. The nosebleeds that happened following that lasted the next two days. The behavioral challenges lasted 3-4 days. I believe that the reaction was the result of an ingredient in the vaccine that caused the events mentioned above. This is the same reaction that my son had when he accidentally ingested PlayDoh because it contained gluten, except for this reaction was worse.
Pt did not receive an adverse reaction rather she was given an expired vaccine. Current HPV vaccine expired on 09/15/12 and she received this vaccine on 09/18/12. This was caught by the office manager during a weekly inventory.
STARTED MILD FEVER THE EVENING OF IMMUNIZATION AND UP TO 103'F AT 36 HRS WITH MACULAR RASHES, RED SWOLLEN FINGER TIPS, CONJUNCTIVAL INJECTION, RED ORAL MUCOSA AND MILD DIARRHEA. MINIMAL CERVICAL LYMPHADENOPATHY. REFERRED TO E.D., DIAGNOSED ATYPICAL KAWASAKI'S AND ADMITTED. RECEIVED IVIGG ONE DOSE AND IMPROVED WITH RESOLUTION OF FEVER AND OTHER SYMPTOMS.  8/14/07 Received vax record from pcp which corrected Prevnar lot #.  VAERS database updated w/same.  8/17/07 Received hospital medical records which reveals patient experienced fever x 2 days, irritability, rash around eyes, cough, emesis x 1, decreased oral intake.  Admitted 8/2-8/6/06.  Exam revealed significant cleral & conjunctival injection, slight edema of hands & feet, diffuse slightly erythematous macular rash over chest & torso.  Tx w/IVIG. & high dose ASA.  Cardiology consult done.  Improved & d/c to home on ASA to be f/u w/cardiology as outpatient. FINAL DX: Atypical Kawasaki's disease, s/p IVIG.
p/vax pt exp T103; cough; joint pain; muscle pain; sore shoulder; tx: antibiotic;
Woke up around 1am and had terrible headache and severe vomiting for 14 hours straight. Eventually ent to ER because committing extensively can be dangerous for dialysis patients. I had a fever 2 degrees higher than my daily Normal and was lathargic and not able to easily cooperate.
This is a spontaneous report from a contactable nurse via a Pfizer sales representative. This nurse reported similar events for three patients. This is the third of three reports. A 76-year-old female patient received on 05Jan2017 17:05 PREVNAR 13 (NDC number 0005197101, lot number R19477, expiry date 01Jan2018) at 0.5 ml single dose in the left deltoid for routine vaccination. Medical history included blood pressure, allergy, acid reflux, high cholesterol, arthralgia of knee and wrist, all ongoing. The patient received influenza vaccine in Sep2016 for immunization. Concomitant medications included amlodipine for blood pressure, metoprolol for blood pressure, hydrochlorothiazide for blood pressure, valsartan for blood pressure, meloxicam, fluticasone propionate (FLUNASE) for allergy and omeprazole (PRILOSEC) for acid reflux, all ongoing. In Jan2017, the patient experienced redness, itching and tenderness at the injection site of pneumococcal 13-val conj vac (dipht crm197 protein).  She came back to the office on 11Jan2017 for a holter monitor and reported to the doctor that she had been experiencing redness, itching and tenderness at the injection site.  Over the past few days the side effects were worsening and the redness was increasing in size.  The doctor advised the patient to monitor the side effects and take Benadryl. Outcome was unknown.
Approximately 10 inch by 8 inch superficial rash noted on the mid to upper back. Localized redness also noted at the left arm injection site (approximately 0.5 cm x 0.5 cm). Client asymptomatic.
3 healthy pregnancies resulting in 3 healthy babies (2012, 2017, 2019)
Crippling pain throughout entire body,  foot swelled until could not put shoes on, brain fog snd exhaustion
After my second Covid 19 shot (administered on 2-12-21), my lower back was so inflamed that the nerves in both arms and my right leg became pinched.   I waited one week but could not handle the pain, numbness and inability to feel my arms and legs. I went back to the Medical center and signed into the sick call.  They gave me a steroid shot and took X-rays. As of today, 3-12-21, I?m still dealing with pinched nerves in both arms and my  right leg. I am waiting to take the X-rays to my spine specialist to see why /how the shot reacted with my spinal fusion.
A consumer report has been received. The report concerns, Female consumer, who had been receiving Nasal FLUMIST. FLUMIST started on an unknown date. The patient experienced sore throat and runny nose. The outcome of the event of sore throat and runny nose is unknown. The report was considered to be non-serious. Corrected report 24-Aug-2012: Initial unit corrected.
Give two booster doses accidently from vials that were expired past their beyond use date; Date the vial was initially stored in the refrigerator-13JAN2022 and date of  administration of vaccine-15FEB2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Give two booster doses accidently from vials that were expired past their beyond use date) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator-13JAN2022 and date of  administration of vaccine-15FEB2022) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Give two booster doses accidently from vials that were expired past their beyond use date) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator-13JAN2022 and date of  administration of vaccine-15FEB2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Give two booster doses accidently from vials that were expired past their beyond use date) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator-13JAN2022 and date of  administration of vaccine-15FEB2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medicines were reported No treatment medicines were reported Date the vial was initially stored in the refrigerator-13JAN2022 6:00AM   This case was linked to MOD-2022-483945 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Feb-2022: Non Significant Follow Up appended
FluBlok was at 8.4 C for more than 24 hrs, patient did received this FluBlok that was out of range, no AE; Initial information received on 20-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (office staff).  This case is linked to 2019SA267191 ; 2019SA267208 ; 2019SA267209; 2019SA267210; 2019SA267211; 2019SA267213; 2019SA267214; 2019SA267215; 2019SA267216; 2019SA267217; 2019SA267218; 2019SA267219; 2019SA267220; 2019SA267221; 2019SA267222; 2019SA267223; 2019SA267224; 2019SA267225; 2019SA267226; 2019SA267227; 2019SA267228; 2019SA267229; 2019SA267230; 2019SA267231; 2019SA267232; 2019SA265193 (same reporter).  This case involves (an adult) male patient who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV], lot QFAA1911, exp date: 27-JUN-2020  via intramuscular route in the left Upper deltoid on an unspecified date which was at 8.4 Degree C for more than 24 hrs and patient did received this flublok that was out of range.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No Concomitant vaccine given.  It was a case of actual medication error due to incorrect product storage.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.
Pt had taken 3rd dose of oral typhoid vaccine. Presented with acute urticaria. Required intervention and management. Product insert does not mention urticaria.
Developed fever, weakness, then a maculopapular rash with small pustules first on chest, then extremities.
Post vax, the patient experienced injection site erythema, pain and edema. The patient was treated wtih cool compress and NSAID.
pt to hosp after a fall at home; hit shoulder; found to be positive for COVID, hypoglycemic, dehydrated, acute on chronic kidney disease; ICU;  AHRF; O2 supplementation, dexamethasone,  ABX; increased confusion and tachycardic; more hypoxic; increased need for O2, placed on BiPAP; DNR/DNI; pt's condition worsened and he was placed on comfort measures only; pt passed away in the hospital
My COVID-19 infection symptoms started on 01/03/2023 at 08:00PM. I had a cough, diarrhea, runny nose, post nasal drip, and slight headache in my eye socket. I did COVID-19 home test 2 times on 01/03/2023 and 01/04/2023. I wasn't sure of the result because I didn't know how to use it at the end of the COVID-19 home test. On 01/05/2023 I did another COVID-19 home test which turned out to be positive. I called my Internist on the same day when I tested positive and he prescribe me with PAXLOVID for 5 days. As of today all my symptoms are gone except the thick green mucus.
Two inches below the site of Vaccination/Injection had swelling, redness, hard and painful. Planning to see Dr. on 11/29/16.